Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Alimentiv-Satisfai-AI

More Like This

PR Newswire associated0

Alimentiv and Satisfai Health Extend Partnership to Accelerate Development of Innovative Imaging Technologies to Tackle GI Disease Challenges

Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related Therapeutics

PR Newswire associated0

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers

Business Wire logo

Ferring Demonstrates Effectiveness of a Treat-to-Target Approach in Mild-to-Moderate Ulcerative Colitis in First Major Study

PR Newswire associated0

Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

PR Newswire associated0

Lancet Digital Health Publishes Study Confirming MAGENTIQ-COLO™ AI-aided Colonoscopy Technology Improves Adenoma Detection Rates

HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024